Actinium Pharmaceuticals Inc
F:7AY1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Actinium Pharmaceuticals Inc
F:7AY1
|
US |
|
C
|
CVS Health Corp
XMUN:CVS
|
US |
|
D
|
Delta Paint PCL
SET:DPAINT
|
TH |
|
IRSA Inversiones y Representaciones SA
F:IRY
|
AR |
|
Tmp Group SpA
F:A72
|
IT |
|
I
|
Industrie Chimiche Forestali SpA
F:IG0
|
IT |
|
F
|
FSN Co Ltd
KOSDAQ:214270
|
KR |
|
Bank Mandiri (Persero) Tbk PT
OTC:PPERF
|
ID |
|
H
|
Halliburton Co
BMV:HAL
|
US |
|
C
|
Central Plaza Hotel PCL
SET:CENTEL
|
TH |
Intrinsic Value
Is 7AY1 undervalued or overvalued?
See the intrinsic value estimate for Actinium Pharmaceuticals Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
7AY1 looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with 7AY1’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Actinium Pharmaceuticals Does
Actinium Pharmaceuticals is a biotechnology company focused on targeted radiation drugs for cancer. Its core idea is to attach a radioactive payload to an antibody so the treatment can seek out specific cancer cells or the cells that make blood and immune systems. The company’s lead work has centered on therapies for hard-to-treat blood cancers, where precise delivery matters because standard chemotherapy can be too blunt.
- Headquarters
- United States of America US
- Employees
- 49
- IPO date
- Mar 26, 2014
Revenue & Expenses Breakdown
Actinium Pharmaceuticals Inc
Earnings Waterfall
Actinium Pharmaceuticals Inc
The intrinsic value for Actinium Pharmaceuticals Inc (7AY1) under the Base Case is hidden EUR.
Compared with the current market price of 0.94 EUR, the stock appears hidden.